Download
s00405-021-06873-8.pdf 828,64KB
WeightNameValue
1000 Titel
  • Mouthrinses against SARS-CoV-2: anti-inflammatory effectivity and a clinical pilot study
1000 Autor/in
  1. Schürmann, Matthias |
  2. Aljubeh, Mohamed |
  3. Tiemann, Carsten |
  4. Sudhoff, Holger |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-05-22
1000 Erschienen in
1000 Quellenangabe
  • 278(12):5059-5067
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00405-021-06873-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140561/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!The scope of this research endeavor was the determination of the applicability of over the counter mouthwash solutions in reducing the viral load in the saliva of COVID-19 patients and hence decreasing their infectivity. Beyond that, new experimental mouthwashes were investigated in terms of a possible positive immune modulation, which might offer an additional opportunity for a positive pharmaceutical effect.!##!Methods!#!The effectivity of the mouth washing solution was determined on 34 hospitalized COVID-19 patients by measuring the viral load by RT-qPCR in pharyngeal swabs, which were taken before and after rinsing. The inflammatory modulation thru the experimental solutions was assayed in an in vitro model of virus infected nasopharyngeal epithelium cells.!##!Results!#!The clinical pilot study demonstrated that the mouth rinsing solution was able to reduce the viral load by about 90% in the saliva of most patients. This reduction was determined to persist for about 6 h. In the experimental solutions, the ingredients dexpanthenol and zinc were able to reduce the expression of proinflammatory cytokines in the cell culture model, while the antiviral response was not altered significantly.!##!Conclusion!#!We recommend the application of mouth wash solutions to COVID-19 patients, since our results indicate a reduction in infectivity and might govern the protection of health care professionals. Further improvement to the over the counter formulation can be made by utilizing zinc and dexpanthenol, as they which might be beneficial for the patients' health.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Dexpanthenol
lokal Mouth wash
lokal Humans [MeSH]
lokal Viral Load [MeSH]
lokal Covid-19
lokal Miscellaneous
lokal Saliva [MeSH]
lokal Zinc
lokal COVID-19 [MeSH]
lokal Pilot Projects [MeSH]
lokal Anti-inflammatory
lokal Anti-Inflammatory Agents [MeSH]
lokal SARS-CoV-2 [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2Now7xybWFubiwgTWF0dGhpYXM=|https://frl.publisso.de/adhoc/uri/QWxqdWJlaCwgTW9oYW1lZA==|https://frl.publisso.de/adhoc/uri/VGllbWFubiwgQ2Fyc3Rlbg==|https://orcid.org/0000-0002-9274-5645
1000 Hinweis
  • DeepGreen-ID: 6582a844ab8a4e53ba2a5b0d3c4730c3 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450428.rdf
1000 Erstellt am 2023-05-09T12:20:43.053+0200
1000 Erstellt von 322
1000 beschreibt frl:6450428
1000 Zuletzt bearbeitet 2023-10-21T03:27:36.588+0200
1000 Objekt bearb. Sat Oct 21 03:27:36 CEST 2023
1000 Vgl. frl:6450428
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450428 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source